IVIG Trials For Off-Label Uses Recommended By HHS Cmte. On Blood Safety
Executive Summary
The efficacy of I.V. immune globulin for off-label indications should be explored by industry and the National Institutes of Health, the HHS Advisory Committee on Blood Safety & Availability recommended April 28.